Clarke Bentley Taylor

This inventor holds 30 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Lycera Corporation, Chiron Corporation, Pfizer Corporation. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clarke Bentley Taylor. Retrieved from https://idiyas.com/inventor/clarke-bentley-taylor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 3)

% Patents Active = 23.3

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 201(Granted Patents)

Company Filing History:

University of Michigan

patents

5. 1 out of 2,538

Warner-Lambert Company

patents

Years Active: 2003-2021

Loading Chart...

Areas of Expertise:

RORγ Agonists

Kinase Inhibitors

Antibacterial Agents

Tetrahydroquinoline

Hydroxamic Acid

Aryl Compounds

Cancer Treatment

Quinolinone Derivatives

Dihydro-2H-benzo

Sulfonamide Compounds

Cellular Therapy

Therapeutic Methods

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11059796 - Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2021-07-13),

2. 10611740 - Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2020-04-07),

3. 10532088 - Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods (2020-01-14),

4. 10442798 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-10-15),

5. 10421751 - Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-09-24),

6. 10392350 - N-substituted pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof (2019-08-27),

7. 10364237 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-07-30),

8. 10189777 - Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease (2019-01-29),

9. 10085972 - [object Object] (2018-10-02),

10. 9932313 - [object Object] (2018-04-03),

11. 9920012 - [object Object] (2018-03-20),

12. 9914706 - [object Object] (2018-03-13),

13. 9896441 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2018-02-20),

14. 9707211 - [object Object] (2017-07-18),

15. 9580391 - [object Object] (2017-02-28),

Title: Clarke Bentley Taylor: Pioneering Inventor from Ann Arbor

Introduction: Clarke Bentley Taylor is a distinguished inventor based in Ann Arbor, MI, known for his groundbreaking contributions to various fields.

Latest Patents: Clarke Bentley Taylor holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Clarke Bentley Taylor has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on society.

Collaborations: Throughout his career, Clarke Bentley Taylor has collaborated with top universities, research institutions, and companies to bring his inventions to life, showcasing his ability to work across disciplines and industries.

Conclusion: Clarke Bentley Taylor's passion for innovation and his dedication to creating meaningful change through his inventions make him a true pioneer in the field of technology and beyond.

Profile summary based on public USPTO records.